Keywords
Coronary heart disease
Estrogen levels
Blood homocysteine
Blood lipids
Submitted : 2024-04-14
Accepted : 2024-04-29
Published : 2024-05-14
Abstract
Objective: To investigate the correlation between estrogen levels, blood homocysteine, and blood lipids in postmenopausal female patients with coronary heart disease. Methods: This study selected 50 postmenopausal female patients with coronary heart disease from Northeast Normal University Hospital (observation group). The data collection period extended from June 2021 to June 2023. Simultaneously, 50 healthy patients with no history of coronary heart disease were selected during the same period as the control group. Physical examinations were conducted for all participants. Estrogen levels, blood homocysteine, and blood lipid levels were tested in both groups. Results: Compared to the control group, the observation group exhibited higher levels of follicle-stimulating hormone (FSH), total cholesterol (TC), and homocysteine (Hcy), and lower levels of high-density lipoprotein cholesterol (HDL-C; P < 0.05). Pearson correlation analysis revealed a negative correlation between estradiol (E2) levels and changes in Hcy, TC, and lowdensity lipoprotein cholesterol (LDL-C) levels (P < 0.01). Multivariate analysis indicated that E2 serves as a protective factor against coronary heart disease in postmenopausal women. Decreased E2 levels, LDL-C, and Hcy were identified as independent risk factors for coronary heart disease in women (P < 0.05). Conclusion: A declining trend in estrogen levels among postmenopausal women has implications for their blood lipid levels and is closely associated with the development of chronic complications of menopause.
References
Wang X, Yuan W, Zhou X, et al., 2022, Study on the Correlation between Blood Rheology and Blood Lipid Levels in Patients with Hyperhomocysteinemia. Heart Journal, 34(6): 659–662.
Wang Y, Huang Y, Ning Y, et al., 2022, Research on Plasma Homocysteine Levels and Related Factors in Pre-and Postmenopausal Women. Chinese Maternal and Child Health Research, 33(4): 6–12.
Zhou Q, Bai J, Zhang J, 2022, Analysis of the Correlation between Serum Homocysteine Levels and Severity of Coronary Heart Disease. Public Health and Preventive Medicine, 33(3): 146–149.
Cai Y, 2023, Analysis of the Correlation between Serum Lipoprotein A-1, Cystatin C, Homocysteine Levels, and Coronary Atherosclerosis in Elderly Patients with Coronary Heart Disease. Chinese Journal of Health Inspection,33(4):479–481 + 486.
Zhang G, Gao Y, Guo X, et al., 2022, Study on the Relationship between Serum Uric Acid, Homocysteine, Interleukin-6, Intestinal Flora, and Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease. Modern Biology Advances in Medicine, 22(12): 2372–2376.
An M, Ran L, Mo F, et al., 2023, The Relationship between Plasma Homocysteine and Bone Density in Postmenopausal Women Undergoing Physical Examination. Chinese Journal of Preventive Medicine, 24(4): 346–351.
Hosseinkhani S, Emamgholipour S, Salari P, et al., 2022, Evaluating the Association between Amino Acid and Acylcarnitine Profiles and Different Levels of Coronary Artery Disease Risk in Postmenopausal Women Using Targeted Metabolomics Technique. Menopause, 29(9): 1062–1070. https://doi.org/10.1097/GME.0000000000002016
Xie L, Liu J, 2023, Analysis of the Correlation between Serum Lipoprotein ?, Homocysteine, and Adverse Cardiovascular and Cerebrovascular Events in Patients with Coronary Heart Disease. Guizhou Medicine, 47(8): 1193–1195.
Jia B, Pang R, Yang R, 2022, The Relationship between Homocysteine Metabolism and the Severity of Spinal Osteoarthritis in Postmenopausal Women. Journal of Neck and Low Back Pain, 43(6): 798–801 + 805.